A leading medical microbiologist, Jaroslav Hrabák, warns that new antibiotics are proving ineffective against increasingly drug-resistant bacteria. His team is focused on developing rapid detection methods for pan-resistant bacteria – those immune to all common antibiotics. Quick identification of these bacteria is crucial, particularly for critically ill patients like those undergoing cancer treatment. Hrabák stresses that faster diagnosis directly improves survival rates for these vulnerable individuals. The research aims to combat the growing threat of infections untreatable with existing medications. This work spotlights the urgent need for innovative approaches to tackle antibiotic resistance globally. The development of rapid detection is a vital step in managing this escalating health crisis.